Table 2 Unit costs and quantity of resource utilization due to PCa, Stockholm region, 2016 (€)

Inpatient care - by DRG

Source

 N01N Radical prostatectomy

Price list from Stockholm region [28]

 N05N Transurethral resection of prostate

 N10C Testes malignancy, operation (OR) procedures, with complications

 N30C Reproductive system malignancy, OR procedures, with complications

 N30E Reproductive system malignancy, OR procedures

 N40C Reproductive system malignancy, other procedures, with complications

 N40E Reproductive system malignancy, other procedures

 N05N Transurethral resection of prostate (Non-primary)

 R40C Radiation therapy, with complications (Non-primary)

 R40E Radiation therapy (Non-primary)

Outpatient care - by DRG

Source

 N32O Reproductive system malignancy, OR procedures

Price list from Stockholm region [28]

 N40O Reproductive system malignancy

 N75O Biopsy, male genitalia, including consultation

 N99X Team consultation for diseases of male genitalia

 N99O Specialist consultation for diseases of male genitalia (Non-primary)

 X11O Radiation therapy, resource-intensive (Non-primary)

 X12O Radiation therapy, including preparatory measures (Non-primary)

 X14O Radiation therapy, less resource-intensive (Non-primary)

Primary care

No. Patients

Source

 GP visit - Diagnostic testing

NBHW, Price list of Stockholm and Southern region [30,31,32]

 GP visit – Monitoring testing

Palliative care

Source

 Hospice/palliative inpatient care

[42,43,44]

 Home support - daily contact of home service

[44]

 Home support - Specialised home-care team

[42, 43]

 Nursing home – permanent

[42]

 Nursing home - short-term

[42]

Pharmaceuticals(Prescribed)- by substance

Source

 L01CD02 – Docetaxel

SPBR, PDR [46]

TLV [40]

 L01CD04 – Cabazitaxel

 L01DB07 – Mitoxantrone

 L02AA02 – Polyestradiol phosphate

 L02AE01 – Buserelin

 L02AE02 – Leuprorelin

 L02AE03 – Goserelin

 L02AE04 – Triptorelin

 L02BB01 – Flutamide

 L02BB03 – Bicalutamide

 L02BB04 – Enzalutamide

 L02BX02 – Degarelix

 L02BX03 – Abiraterone

Informal care

Source

 Severely limited in daily activity - outside

SCB [48]

 Severely limited in daily activity - inside

 Terminally ill

Productivity losses - morbidity

Source

 Short-term sick leave

SCB [48]

 Long-term sick leave

Productivity losses - pre-mature mortality

Source

 Pre-mature mortality

SCB [48]